Combining enzalutamide with PARP inhibitors: Pharmaceutically induced BRCAness

Research output: Contribution to journalEditorialpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)93315-93316
Number of pages2
JournalOncotarget
Volume8
Issue number55
DOIs
StatePublished - Nov 1 2017

Keywords

  • Castration-resistant prostate cancer
  • Combination therapy
  • Enzalutamide
  • PARP inhibitors

ASJC Scopus subject areas

  • Oncology

Cite this